268 related articles for article (PubMed ID: 12213856)
1. High reliability of neonatal screening for congenital adrenal hyperplasia in Switzerland.
Steigert M; Schoenle EJ; Biason-Lauber A; Torresani T
J Clin Endocrinol Metab; 2002 Sep; 87(9):4106-10. PubMed ID: 12213856
[TBL] [Abstract][Full Text] [Related]
2. Newborn screening for congenital adrenal hyperplasia in Cuba: six years of experience.
González EC; Carvajal F; Frómeta A; Arteaga AL; Castells EM; Espinosa T; Coto R; Pérez PL; Tejeda Y; Del Río L; Segura MT; Almenares P; Robaina R; Fernández JL
Clin Chim Acta; 2013 Jun; 421():73-8. PubMed ID: 23481450
[TBL] [Abstract][Full Text] [Related]
3. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
Kopacek C; de Castro SM; Prado MJ; da Silva CM; Beltrão LA; Spritzer PM
BMC Pediatr; 2017 Jan; 17(1):22. PubMed ID: 28095810
[TBL] [Abstract][Full Text] [Related]
4. Neonatal screening for congenital adrenal hyperplasia in North-Eastern Italy: a report three years into the program.
Cavarzere P; Camilot M; Teofoli F; Tatò L
Horm Res; 2005; 63(4):180-6. PubMed ID: 15818055
[TBL] [Abstract][Full Text] [Related]
5. Two-year pilot study of newborn screening for congenital adrenal hyperplasia in New South Wales compared with nationwide case surveillance in Australia.
Gleeson HK; Wiley V; Wilcken B; Elliott E; Cowell C; Thonsett M; Byrne G; Ambler G
J Paediatr Child Health; 2008 Oct; 44(10):554-9. PubMed ID: 19012627
[TBL] [Abstract][Full Text] [Related]
6. Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study.
Tsuji A; Konishi K; Hasegawa S; Anazawa A; Onishi T; Ono M; Morio T; Kitagawa T; Kashimada K
BMC Pediatr; 2015 Dec; 15():209. PubMed ID: 26671474
[TBL] [Abstract][Full Text] [Related]
7. Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995.
Balsamo A; Cacciari E; Piazzi S; Cassio A; Bozza D; Pirazzoli P; Zappulla F
Pediatrics; 1996 Sep; 98(3 Pt 1):362-7. PubMed ID: 8784357
[TBL] [Abstract][Full Text] [Related]
8. Nationwide neonatal screening for congenital adrenal hyperplasia in sweden: a 26-year longitudinal prospective population-based study.
Gidlöf S; Wedell A; Guthenberg C; von Döbeln U; Nordenström A
JAMA Pediatr; 2014 Jun; 168(6):567-74. PubMed ID: 24733564
[TBL] [Abstract][Full Text] [Related]
9. Screening for congenital adrenal hyperplasia: adjustment of 17-hydroxyprogesterone cut-off values to both age and birth weight markedly improves the predictive value.
Olgemöller B; Roscher AA; Liebl B; Fingerhut R
J Clin Endocrinol Metab; 2003 Dec; 88(12):5790-4. PubMed ID: 14671170
[TBL] [Abstract][Full Text] [Related]
10. False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values.
Fingerhut R
Steroids; 2009 Aug; 74(8):662-5. PubMed ID: 19463687
[TBL] [Abstract][Full Text] [Related]
11. Neonatal screening for congenital adrenal hyperplasia in Taiwan: a pilot study.
Chu SY; Tsai WY; Chen LH; Wei ML; Chien YH; Hwu WL
J Formos Med Assoc; 2002 Oct; 101(10):691-4. PubMed ID: 12517042
[TBL] [Abstract][Full Text] [Related]
12. Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.
Seo JY; Park HD; Kim JW; Oh HJ; Yang JS; Chang YS; Park WS; Lee SY
J Perinat Med; 2014 Jan; 42(1):121-7. PubMed ID: 23989111
[TBL] [Abstract][Full Text] [Related]
13. A three-year follow-up of congenital adrenal hyperplasia newborn screening.
Pezzuti IL; Barra CB; Mantovani RM; Januário JN; Silva IN
J Pediatr (Rio J); 2014; 90(3):300-7. PubMed ID: 24560529
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Dutch neonatal screening for congenital adrenal hyperplasia.
van der Linde AAA; Schönbeck Y; van der Kamp HJ; van den Akker ELT; van Albada ME; Boelen A; Finken MJJ; Hannema SE; Hoorweg-Nijman G; Odink RJ; Schielen PCJI; Straetemans S; van Trotsenburg PS; Claahsen-van der Grinten HL; Verkerk PH
Arch Dis Child; 2019 Jul; 104(7):653-657. PubMed ID: 30712004
[TBL] [Abstract][Full Text] [Related]
15. Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls.
Varness TS; Allen DB; Hoffman GL
J Pediatr; 2005 Oct; 147(4):493-8. PubMed ID: 16227036
[TBL] [Abstract][Full Text] [Related]
16. Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia.
Votava F; Török D; Kovács J; Möslinger D; Baumgartner-Parzer SM; Sólyom J; Pribilincová Z; Battelino T; Lebl J; Frisch H; Waldhauser F;
Eur J Endocrinol; 2005 Jun; 152(6):869-74. PubMed ID: 15941926
[TBL] [Abstract][Full Text] [Related]
17. Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden.
Thil'en A; Nordenström A; Hagenfeldt L; von Döbeln U; Guthenberg C; Larsson A
Pediatrics; 1998 Apr; 101(4):E11. PubMed ID: 9521977
[TBL] [Abstract][Full Text] [Related]
18. Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia.
Minutti CZ; Lacey JM; Magera MJ; Hahn SH; McCann M; Schulze A; Cheillan D; Dorche C; Chace DH; Lymp JF; Zimmerman D; Rinaldo P; Matern D
J Clin Endocrinol Metab; 2004 Aug; 89(8):3687-93. PubMed ID: 15292289
[TBL] [Abstract][Full Text] [Related]
19. [Neonatal screening for congenital adrenal hyperplasia in Shanghai areas].
Gu X; Zhou J; Ye J
Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Jan; 36(1):16-8. PubMed ID: 11955341
[TBL] [Abstract][Full Text] [Related]
20. Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia.
Therrell BL; Berenbaum SA; Manter-Kapanke V; Simmank J; Korman K; Prentice L; Gonzalez J; Gunn S
Pediatrics; 1998 Apr; 101(4 Pt 1):583-90. PubMed ID: 9521938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
